Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized open-label study in first-line advanced biliary tract cancer
TCTR20260616001Phase 3Not yet recruiting
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in biliary cancer, sponsored by Taiho Pharmaceutical Co., Ltd. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
biliary cancer
Beyond the preview
Go deeper on TCTR20260616001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260616001.